2021 revised algorithm for the management of knee osteoarthritis—the Chinese viewpoint

被引：0
作者：
Zhiyi Zhang
Cibo Huang
Yongping Cao
Rong Mu
Mun Chan Zhang
Dan Xing
Dongwei Fan
Yunpong Ding
Junhuan Guo
Yong Hou
Lin Jianhao
Nicola Veronese
Jean-Yves Reginster
Olivier Bruyere
Etienne Cavalier
Huaihuan Zhang
机构：
[1] The First Affiliated Hospital of Harbin Medical University,Department of Rheumatology
[2] Beijing Hospital,Department of Rheumatology
[3] Peking University First Hospital,Department of Orthopedics
[4] Peking University People’s Hospital,Arthritis Clinic and Research Center
[5] Peking University,Department of Orthopedics
[6] Peking University Third Hospital,Department of Orthopedics
[7] The Affiliated Hospital of Academy of Military Medical Sciences,Department of Rheumatology and Clinical Immunology
[8] PLA 307Th Hospital,Department of Internal Medicine and Geriatrics
[9] Peking Union Medical College Hospital,Department of Public Health, Epidemiology and Health Economics
[10] Chinese Academy of Medical Sciences,Department of Clinical Chemistry
[11] Peking Union Medical College,Department of Science and Technology
[12] National Clinical Research Center for Dermatologic and Immunologic Diseases,undefined
[13] Geriatric Unit,undefined
[14] University of Palermo,undefined
[15] WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging,undefined
[16] University of Liège,undefined
[17] CHU Sart Tilman B23,undefined
[18] University of Liège,undefined
[19] CHU de Liège,undefined
[20] China Electric Power Research Institute,undefined
来源：
Aging Clinical and Experimental Research | 2021年 / 33卷
关键词：
Knee osteoartrhitis; Patented crystalline glucosamine sulfate; Symptomatic slow-acting drugs for osteoarthritis; Algorithm; China;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2141 / 2147
页数：6
相关论文
共 214 条
[1]  
Murray CJ(2012)Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2197-2223
[2]  
Vos T(2003)Burden of major musculoskeletal conditions Bull World Health Organ 81 646-656
[3]  
Lozano R(2012)Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2163-2196
[4]  
Woolf AD(2014)The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study Ann Rheum Dis 73 1323-1330
[5]  
Pfleger B(2019)Impact of osteoarthritis on activities of daily living: does joint site matter? Aging Clin Exp Res 31 1049-1056
[6]  
Vos T(2018)Quality of life assessment in musculo-skeletal health Aging Clin Exp Res 30 413-418
[7]  
Flaxman AD(2014)An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) Semin Arthritis Rheum 44 253-263
[8]  
Naghavi M(2019)Safety of topical non-steroidal anti-inflammatory drugs in osteoarthritis: outcomes of a systematic review and meta-analysis Drugs Aging 36 45-64
[9]  
Cross M(2019)Safety of intra-articular hyaluronic acid injections in osteoarthritis: outcomes of a systematic review and meta-analysis Drugs Aging 36 101-127
[10]  
Smith E(2019)Safety of oral non-selective non-steroidal anti-inflammatory drugs in osteoarthritis: what does the literature say? Drugs Aging 36 15-24
12345678910